Albert Edwards, MD
Retina Specialist · Eugene, ORNPI 1215930763
Payments from drug & device makers
Across 313 payments — averaging $8636.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$614K
- Boehringer Ingelheim$494K
- Apellis Pharmaceuticals, Inc.$472K
- Roche TCRC, Inc.$304K
- Hexal AG$240K
- Boehringer Ingelheim International GmbH$195K
- plus $384K from 22 others
What the payments were for
- Speaking & faculty fees$93410%
- Travel & lodging$96911%
- Food & beverage$1,71019%
- Education$1081%
- Other$5,50360%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 13 | $613,967 |
| Boehringer Ingelheim | 22 | $493,963 |
| Apellis Pharmaceuticals, Inc. | 44 | $471,925 |
| Roche TCRC, Inc. | 25 | $303,833 |
| Hexal AG | 17 | $239,927 |
| Boehringer Ingelheim International GmbH | 96 | $195,294 |
| Eyepoint US, Inc. | 2 | $119,127 |
| Janssen Research & Development, LLC | 17 | $104,571 |
| Aerie Pharmaceuticals, Inc. | 10 | $40,350 |
| Alcon Research LLC | 12 | $39,667 |
| Sanofi US Services Inc. | 5 | $27,631 |
| Regeneron | 13 | $27,586 |
| Astellas Pharma Global Development | 1 | $7,793 |
| Carl Zeiss Meditec Digital Innovations LLC | 1 | $5,503 |
| AstraZeneca | 1 | $5,350 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 14 | $4,312 |
| Carl Zeiss Meditec USA, Inc. | 2 | $1,054 |
| Bausch & Lomb Americas Inc. | 2 | $218 |
| Rxsight Inc | 3 | $159 |
| Alcon | 1 | $147 |
| Genentech, Inc. | 3 | $143 |
| Tarsus Pharmaceuticals, Inc. | 1 | $130 |
| Regeneron Healthcare Solutions, Inc. | 1 | $115 |
| Sun Pharmaceutical Industries Inc. | 1 | $107 |
| Heidelberg Engineering, Inc. | 1 | $94 |
| Novo Nordisk | 2 | $54 |
| AbbVie | 2 | $28 |
| Biotissue Holdings Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VERACITY SURGICAL$6,472
- ARTEVO 800$969
- CIRRUS HD-OCT$969
- IOLMaster 700$969
- VisuMax$969
- Clareon PanOptix Pro$147
- STELLARIS$145
- XDEMVY$130
- EYLEA$115
- CEQUA$107
How this compares
$2,703,070 in reported general payments places this provider in the 95th percentile of 36 retina specialist providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 121 | $6,385 |
| Fluorometholone | 12 | $1,399 |
| Doxycycline Hyclate | 34 | $1,000 |
| Latanoprost | 69 | $989 |
| Ofloxacin | 72 | $926 |
| Timolol Maleate | 86 | $655 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 30 | $365 |
| Brimonidine Tartrate | 30 | $179 |
| Ketorolac Tromethamine | 11 | $157 |
| Prednisone | 11 | $40 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Eugene
- Allan HunterEugene$598K
- Paul TlucekPortland$4.8M
- Christopher AdermanTroutdale$1.7M
- Apurva PatelPortland$1.1M
- Brian Chan KaiPortland$837K
- David WilsonPortland$498K
- Michael LeePortland$479K
- Christina FlaxelPortland$358K
- John CampbellPortland$302K
- Brandon LujanPortland$147K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.